Compound Detail
CHEMBL2059499
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]8O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]8OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]7OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@]12C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Basic Information
| ChEMBL ID | CHEMBL2059499 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PHIUHBOJEMIHQZ-YAPWIAIGSA-A |
| Parent Compound | CHEMBL2078841 |
| Active Moiety | CHEMBL2078841 |
7
Targets
11
Activities
3
Assay Types
1
PK Parameters
18
Publications
0
Known Names
Molecular Properties
2078.1
MW (Da)
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 6.91
Kd 4 meas. best 8.1
Ki 1 meas. best 8.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Heparanase CHEMBL3921 | Ki | 8.21 | 8.21 | 6.1 | 1 |
| Fibroblast growth factor 1 CHEMBL2120 | Kd | 8.1 | 8.1 | 8.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 7.54 | 7.54 | 28.9 | 1 |
| Heparanase CHEMBL3921 | IC50 | 6.91 | 6.91 | 123.0 | 1 |
| Fibroblast growth factor 2 CHEMBL3107 | Kd | 6.41 | 6.41 | 390.0 | 1 |
| HUVEC CHEMBL613979 | IC50 | 6.3 | 6.02 | 500.0 | 4 |
| Aorta CHEMBL613606 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Spike glycoprotein CHEMBL4662936 | Kd | 5.04 | 5.04 | 9120.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 50.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22458531 | 10.1021/jm201708h | HUVEC | 10 |
| 22458531 | 10.1021/jm201708h | Aorta | 5 |
| 38995734 | 10.1021/acs.jmedchem.4c00487 | Spike glycoprotein | 3 |
| 22458531 | 10.1021/jm201708h | NON-PROTEIN TARGET | 3 |
| 38995734 | 10.1021/acs.jmedchem.4c00487 | SARS-CoV-2 | 2 |
| 22458531 | 10.1021/jm201708h | Plasma | 2 |
| 37981443 | 10.1016/j.ejmech.2023.115923 | Respiratory syncytial virus | 1 |
| 38995734 | 10.1021/acs.jmedchem.4c00487 | Vero C1008 | 1 |
| 38995734 | 10.1021/acs.jmedchem.4c00487 | Heparanase | 1 |
| 38995734 | 10.1021/acs.jmedchem.4c00487 | Human alphaherpesvirus 2 | 1 |
| 38995734 | 10.1021/acs.jmedchem.4c00487 | Respiratory syncytial virus | 1 |
| 37981443 | 10.1016/j.ejmech.2023.115923 | SARS-CoV-2 | 1 |
| 37981443 | 10.1016/j.ejmech.2023.115923 | Spike glycoprotein/Angiotensin-converting enzyme 2 | 1 |
| 22458531 | 10.1021/jm201708h | Heparanase | 1 |
| 22458531 | 10.1021/jm201708h | Unchecked | 1 |
| 22458531 | 10.1021/jm201708h | Fibroblast growth factor 2 | 1 |
| 22458531 | 10.1021/jm201708h | Fibroblast growth factor 1 | 1 |
| 22458531 | 10.1021/jm201708h | Rattus norvegicus | 1 |
Data from ChEMBL 36 via Core Engine